Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Pseudoexfoliation Glaucoma: Clinical Presentation and Therapeutic Options 2023-08-01
  2. Recent Trends in the Management of Alzheimer's Disease: Current Therapeutic Options and Drug Repurposing Approaches 2020-01-01

Studies

2 studies carry this tag.

Date range

2020 to 2023

Top journals

  • Current neuropharmacology 1
  • Turkish journal of ophthalmology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Pseudoexfoliation Glaucoma: Clinical Presentation and Therapeutic Options

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Turkish journal of ophthalmology 2023-08-01 Risk factors

    Pseudoexfoliation syndrome (PES) is one of the most common causes of open-angle glaucoma, with a higher risk of vision loss, a higher maximum and mean intraocular pressure (IOP) at diagnosis, and a wider range of IOP fluctuation compared to primary open-angle glaucoma.

  2. Recent Trends in the Management of Alzheimer's Disease: Current Therapeutic Options and Drug Repurposing Approaches

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Current neuropharmacology 2020-01-01 Drug development

    Alzheimer's disease is one of the most progressive forms of dementia, ultimately leading to death in aged populations.

All topic tags with their study counts